Zenith Drugs Limited Share Price & Stock Analysis

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated in 1956 and is based in Indore, India.

Key Metrics

Current Price	₹39.00
Market Cap	₹70 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Biotechnology and Life Sciences > Pharmaceuticals
P/E Ratio	17
52-Week Range	₹33.30 – ₹65.50
Beta (1Y)	0.83
Dividend Yield	0.00%

Business Segments

1. Manufacturing and Trading of Medicines-100%

Peer Companies

• Abbott India Ltd.
• Ajanta Pharma Limited
• Emcure Pharmaceuticals Ltd
• Piramal Pharma Ltd
• RUBICON RESEARCH LIMITED
• Caplin Point Laboratories Ltdte
• Pfizer Ltd.
• Eris Lifesciences Ltd

Frequently Asked Questions

What is the current share price of Zenith Drugs Limited?

Zenith Drugs Limited is trading at ₹39.00, with a market capitalisation of ₹70 Cr.

Which sector does Zenith Drugs Limited belong to?

Zenith Drugs Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Zenith Drugs Limited?

Zenith Drugs Limited has a P/E of 17.